MaxCyte Inc (MXCT)
3.55
+0.10
(+2.90%)
USD |
NASDAQ |
Nov 22, 16:00
3.565
+0.02
(+0.42%)
After-Hours: 20:00
MaxCyte Gross Profit Margin (Quarterly): 76.38% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 76.38% |
| June 30, 2024 | 85.73% |
| March 31, 2024 | 87.63% |
| December 31, 2023 | 89.96% |
| September 30, 2023 | 90.09% |
| June 30, 2023 | 84.78% |
| March 31, 2023 | 88.34% |
| December 31, 2022 | 87.55% |
| September 30, 2022 | 87.14% |
| Date | Value |
|---|---|
| June 30, 2022 | 88.34% |
| March 31, 2022 | 90.83% |
| December 31, 2021 | 87.92% |
| September 30, 2021 | 90.69% |
| June 30, 2021 | 88.96% |
| March 31, 2021 | 89.33% |
| December 31, 2020 | 89.35% |
| September 30, 2020 | 89.13% |
| June 30, 2020 | 90.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
76.38%
Minimum
Sep 2024
90.95%
Maximum
Jun 2020
87.95%
Average
88.65%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cutera Inc | 5.58% |
| IRIDEX Corp | 37.33% |
| Stereotaxis Inc | 44.57% |
| Electromed Inc | 78.34% |
| Myomo Inc | 75.43% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.86% |
| Return on Assets | -13.82% |
| Return on Invested Capital | -15.86% |
| Profit Margin (Quarterly) | -141.6% |
| Operating Margin (Quarterly) | -172.1% |
| Return on Net Operating Assets | -70.36% |